1. Home
  2. ACAD vs AWR Comparison

ACAD vs AWR Comparison

Compare ACAD & AWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACAD
  • AWR
  • Stock Information
  • Founded
  • ACAD 1993
  • AWR 1929
  • Country
  • ACAD United States
  • AWR United States
  • Employees
  • ACAD N/A
  • AWR N/A
  • Industry
  • ACAD Biotechnology: Pharmaceutical Preparations
  • AWR Water Supply
  • Sector
  • ACAD Health Care
  • AWR Utilities
  • Exchange
  • ACAD Nasdaq
  • AWR Nasdaq
  • Market Cap
  • ACAD 3.5B
  • AWR 2.8B
  • IPO Year
  • ACAD 2004
  • AWR N/A
  • Fundamental
  • Price
  • ACAD $21.09
  • AWR $77.10
  • Analyst Decision
  • ACAD Buy
  • AWR Sell
  • Analyst Count
  • ACAD 20
  • AWR 2
  • Target Price
  • ACAD $29.25
  • AWR $77.50
  • AVG Volume (30 Days)
  • ACAD 2.5M
  • AWR 263.3K
  • Earning Date
  • ACAD 11-05-2025
  • AWR 11-05-2025
  • Dividend Yield
  • ACAD N/A
  • AWR 2.67%
  • EPS Growth
  • ACAD 615.00
  • AWR 13.49
  • EPS
  • ACAD 1.33
  • AWR 3.26
  • Revenue
  • ACAD $1,018,885,000.00
  • AWR $615,959,000.00
  • Revenue This Year
  • ACAD $14.01
  • AWR $10.72
  • Revenue Next Year
  • ACAD $11.81
  • AWR $3.98
  • P/E Ratio
  • ACAD $15.76
  • AWR $23.15
  • Revenue Growth
  • ACAD 14.41
  • AWR 8.55
  • 52 Week Low
  • ACAD $13.40
  • AWR $69.85
  • 52 Week High
  • ACAD $26.65
  • AWR $87.23
  • Technical
  • Relative Strength Index (RSI)
  • ACAD 43.19
  • AWR 68.31
  • Support Level
  • ACAD $20.33
  • AWR $72.99
  • Resistance Level
  • ACAD $22.10
  • AWR $76.00
  • Average True Range (ATR)
  • ACAD 0.78
  • AWR 1.47
  • MACD
  • ACAD 0.08
  • AWR 0.61
  • Stochastic Oscillator
  • ACAD 58.09
  • AWR 97.58

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

About AWR American States Water Company

American States Water Co is water and utilities holding company based in California. The segments of the firm include water, electric and contracted services. Within these segments, American States Water conducts water and electric operations through Golden State Water Company and Bear Valley Electric Service, Inc while contracted services through American States Utility Services and its subsidiaries. Golden State Water conducts its operations across various counties in California and is regulated by the California Public Utilities Commission. American States Utility Services has contracted with the U.S. government to provide water services to various military installations. The majority of the company's revenue is derived from water services from commercial and residential customers.

Share on Social Networks: